Quest Diagnostics Inc Payments to Acquire Businesses, Gross
Quest Diagnostics Inc (DGX) reported Payments to Acquire Businesses, Gross of $101.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2026-02-26
- Quest Diagnostics Inc payments to acquire businesses, gross for the quarter ending 2025-12-31 was $50.00M, a 86.95% decline year-over-year.
- Quest Diagnostics Inc payments to acquire businesses, gross for the quarter ending 2025-09-30 was $34.00M, a 97.85% decline year-over-year.
- Quest Diagnostics Inc payments to acquire businesses, gross for the quarter ending 2025-06-30 was $17.00M, a 83.96% decline year-over-year.
- Quest Diagnostics Inc payments to acquire businesses, gross for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Quest Diagnostics Inc payments to acquire businesses, gross for fiscal 2025 was $101.00M, a 95.44% decline from fiscal 2024.
- Quest Diagnostics Inc payments to acquire businesses, gross for fiscal 2024 was $2.21B, a 261.76% increase from fiscal 2023.
- Quest Diagnostics Inc payments to acquire businesses, gross for fiscal 2023 was $612.00M, a 313.51% increase from fiscal 2022.
- Quest Diagnostics Inc payments to acquire businesses, gross for fiscal 2022 was $148.00M, a 55.29% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $84.00M derived: sum of 2 quarters · filed 2026-02-26 | $101.00M derived: sum of 3 quarters · filed 2026-02-26 | $101.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $34.00M 10-Q · filed 2025-10-21 | $51.00M derived: sum of 2 quarters · filed 2025-10-21 | $51.00M 10-Q · filed 2025-10-21 | $434.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $17.00M 10-Q · filed 2025-07-23 | $17.00M 10-Q · filed 2025-07-23 | $400.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.98B derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-23 | $383.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.97B derived: sum of 3 quarters · filed 2026-02-26 | $2.07B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $383.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.97B derived: sum of 2 quarters · filed 2026-02-26 | $2.07B derived: sum of 3 quarters · filed 2026-02-26 | $2.21B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.58B 10-Q · filed 2025-10-21 | $1.69B derived: sum of 2 quarters · filed 2025-10-21 | $1.83B 10-Q · filed 2025-10-21 | $1.83B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $106.00M 10-Q · filed 2025-07-23 | $248.00M 10-Q · filed 2025-07-23 | $248.00M derived: sum of 3 quarters · filed 2026-02-26 | $250.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $142.00M 10-Q · filed 2025-04-23 | $142.00M derived: sum of 2 quarters · filed 2026-02-26 | $144.00M derived: sum of 3 quarters · filed 2026-02-26 | $723.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $581.00M derived: sum of 3 quarters · filed 2026-02-26 | $612.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.00M 10-Q · filed 2024-10-23 | $581.00M derived: sum of 2 quarters · filed 2024-10-23 | $612.00M 10-Q · filed 2024-10-23 | $650.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $579.00M 10-Q · filed 2024-07-24 | $610.00M 10-Q · filed 2024-07-24 | $648.00M derived: sum of 3 quarters · filed 2025-02-20 | $648.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $31.00M 10-Q · filed 2024-04-24 | $69.00M derived: sum of 2 quarters · filed 2025-02-20 | $69.00M derived: sum of 3 quarters · filed 2025-02-20 | $70.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $38.00M derived: sum of 2 quarters · filed 2025-02-20 | $39.00M derived: sum of 3 quarters · filed 2025-02-20 | $148.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-25 | $1.00M derived: sum of 2 quarters · filed 2023-10-25 | $110.00M 10-Q · filed 2023-10-25 | $190.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-07-27 | $110.00M 10-Q · filed 2023-07-27 | $190.00M derived: sum of 3 quarters · filed 2024-02-22 | $210.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $109.00M 10-Q · filed 2023-04-28 | $189.00M derived: sum of 2 quarters · filed 2024-02-22 | $209.00M derived: sum of 3 quarters · filed 2024-02-22 | $440.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $100.00M derived: sum of 2 quarters · filed 2024-02-22 | $331.00M derived: sum of 3 quarters · filed 2024-02-22 | $331.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $20.00M 10-Q · filed 2022-10-21 | $251.00M derived: sum of 2 quarters · filed 2022-10-21 | $251.00M 10-Q · filed 2022-10-21 | $252.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $231.00M 10-Q · filed 2022-07-22 | $231.00M 10-Q · filed 2022-07-22 | $232.00M derived: sum of 3 quarters · filed 2023-02-21 | $351.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-22 | $1.00M derived: sum of 2 quarters · filed 2023-02-21 | $120.00M derived: sum of 3 quarters · filed 2023-02-21 | $240.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $120.00M derived: sum of 2 quarters · filed 2023-02-21 | $240.00M derived: sum of 3 quarters · filed 2023-02-21 | $351.00M 10-K · filed 2023-02-21 |
| 2020-09-30 | $119.00M 10-Q · filed 2021-10-22 | $239.00M derived: sum of 2 quarters · filed 2021-10-22 | $350.00M 10-Q · filed 2021-10-22 | $352.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $120.00M 10-Q · filed 2020-07-24 | $231.00M 10-Q · filed 2020-07-24 | $233.00M derived: sum of 3 quarters · filed 2022-02-28 | $233.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $111.00M 10-Q · filed 2020-05-04 | $113.00M derived: sum of 2 quarters · filed 2022-02-28 | $113.00M derived: sum of 3 quarters · filed 2022-02-28 | $113.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.00M derived: sum of 2 quarters · filed 2022-02-28 | $2.00M derived: sum of 3 quarters · filed 2022-02-28 | $58.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-23 | $0.00 derived: sum of 2 quarters · filed 2020-10-23 | $56.00M 10-Q · filed 2020-10-23 | $259.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-24 | $56.00M 10-Q · filed 2020-07-24 | $259.00M derived: sum of 3 quarters · filed 2021-02-22 | $313.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $56.00M 10-Q · filed 2020-05-04 | $259.00M derived: sum of 2 quarters · filed 2021-02-22 | $313.00M derived: sum of 3 quarters · filed 2021-02-22 | |
| 2018-12-31 | $203.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $257.00M derived: sum of 2 quarters · filed 2021-02-22 | $427.00M 10-K · filed 2021-02-22 | |
| 2018-09-30 | $54.00M 10-Q · filed 2019-10-23 | $224.00M 10-Q · filed 2019-10-23 | ||
| 2017-12-31 | $593.00M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |